References

  1. Rüegger CM, Lindner M, Ballhausen D, Baumgartner MR, Beblo S, Das A et al. Cross-sectional observational study of 208 patients with non-classical urea cycle disorders. J Inherit Metab Dis. 2014 Jan; 37(1):21-30. PubMed | Google Scholar

  2. Martin-Hernandez E, Aldamiz-Echevarria L, Castejon-Ponce E, Pedron-Giner C, Couce ML, Serrano-Nietto J et al. Urea cycle disorders in Spain: an observational, cross-sectional and multicentric study of 104 cases. Orphanet J Rare Dis. 2014; 9:187. Google Scholar

  3. Maillot F, Crenn P. Déficits du cycle de l'urée chez les patients adultes. Rev Neurol. 2007; 163(10):897-903. Google Scholar

  4. Adeva MM, Souto G, Blanco N, Donapetry C. Ammonium metabolism in humans. Metabolism. 2012; 61(11):1495-511. PubMed | Google Scholar

  5. Bosoi CR, Rose CF. Identifying the direct effects of ammonia on the brain. Metab Brain Dis. 2009; 24(1):95-102. PubMed | Google Scholar

  6. Batshaw ML, Tuchman M, Summar ML, Seminara J. A longitudinal study of urea cycle disorders. Mol Genet Metab. 2014; 113(1-2):127-30. PubMed | Google Scholar

  7. Fassier T, Guffon N, Acquaviva C, D'Amato T, Durand DV, Domenech P. Misdiagnosed postpartum psychosis revealing a late-onset urea cycle disorder. Am J Psychiatry. 2011; 168(6):576-80. PubMed | Google Scholar

  8. Bogdanovic MD, Kidd D, Briddon A, Duncan JS, Land JM. Late onset heterizygous ornithine transcarbamylase deficiency mimicking complex partial status epilepticus. J Neurol Neurosurg Psychiatry. 2000; 69(6):813-5. PubMed | Google Scholar

  9. Nassogne MC, Heron B, Touati G, Rabier D, Saudubray JM. Urea cycle defects: management and outcome. J Inherit Metab Dis. 2005; 28(3):407-14. PubMed | Google Scholar

  10. Blans MJ, Vos PE, Faber HJ, Boers GHJ. Coma in a young anorexic woman. Lancet. 2001; 357(9272):1944. PubMed | Google Scholar

  11. Di Magno EP, Lowe JE, Snodgrass PJ, Jones JD. Ornithine transcarbamylase deficiency: a cause of bizarre behaviour in a man. N Engl J Med. 1986; 315:744-7. Google Scholar

  12. Msall M, Monahan PS, Chapanis N, Batshaw ML. Cognitive development in children with inborn errors of urea synthesis. Acta Paediatr Jpn. 1988; 30(4):435-41. PubMed | Google Scholar

  13. Maestri NE, Lord C, Glynn M et al. The phenotype of ostensibly healthy women who are carriers for ornithine transcarbamylase deficiency. Medicine. 1998; 77(6):389-97. PubMed | Google Scholar

  14. Chang MY, Fang JT, Chen YC et al. Continuous venovenous haemofiltration in hyperammonaemic coma of an adult with non-diagnosed partial ornithine transcarbamylase deficiency. Nephrol Dial Transplant. 1999; 14(5):1282-4. PubMed | Google Scholar

  15. Hawks-Arn P, Hauser ER, Thomas GH et al. Hyperammonemia in women with a mutation at the OTC locus. N Engl J Med. 1990; 322(23):1652-5.

  16. Peterson DE, Dirk E. Acute postpartum mental status change and coma caused by previously undiagnodes ornithine transcarbamylase deficiency. Obset Gynecol. 2003; 102(5):S1212-5. PubMed | Google Scholar

  17. Kamoun PP, Rabier D. Valproate-induced inhibition of urea synthesis. Lancet. 1987; 1(8523):48. PubMed | Google Scholar

  18. Oeschner M, Steen C, Stürenbrug HJ, Kohlschütter A. Hyperammonaemic encephalopathy after initiation of valproate therapy in unrecognised ornithine transcarbamylase deficiency. J Neurol Neurosurg Psychiatry. 1998; 64(5):680-2. PubMed | Google Scholar

  19. Mc Cullough BA, Yudkoff M, Batshaw ML et al. Genotype spectrum of ornithine transcarbamylase deficiency: correlation with the clinical and biochemical phenotype. Am J Med Genet. 2000; 93(4):313-9. PubMed | Google Scholar